Back
Fulcrum Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
FULC
Fulcrum Therapeutics, Inc.
Last Price:
$8.03
Seasonality Move:
15.71%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Fulcrum Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.14 | Buy |
| 20-day SMA: | 7.34 | Buy |
| 50-day SMA: | 8.96 | Sell |
| 200-day SMA: | 8.79 | Sell |
| 8-day EMA: | 7.35 | Buy |
| 20-day EMA: | 7.55 | Buy |
| 50-day EMA: | 8.51 | Sell |
| 200-day EMA: | 8.54 | Sell |
Fulcrum Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 52.84 | Buy |
| Chaikin Money Flow: | 837350 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.94 - 8.04) | Buy |
| Bollinger Bands (100): | (8.03 - 11.71) | Sell |
Fulcrum Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics, Inc. Stock
Is Fulcrum Therapeutics, Inc. Stock a Buy?
-
Fulcrum Therapeutics, Inc. share price is 8.04 while FULC 8-day simple moving average is 7.14, which is a Buy signal.
-
The stock price of FULC is 8.04 while Fulcrum Therapeutics, Inc. 20-day SMA is 7.34, which makes it a Buy.
-
Fulcrum Therapeutics, Inc. 50-day simple moving average is 8.96 while FULC share price is 8.04, making it a Sell technically.
-
FULC stock price is 8.04 and Fulcrum Therapeutics, Inc. 200-day simple moving average is 8.79, creating a Sell signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
40
Fulcrum Therapeutics, Inc. (FULC)
is a Sell
Is Fulcrum Therapeutics, Inc. a Buy or a Sell?
-
Fulcrum Therapeutics, Inc. stock is rated a SellThe current Fulcrum Therapeutics, Inc. [FULC] share price is $8.04. The Score for FULC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics, Inc. Stock Info
Market Cap:
574.8M
Price in USD:
8.04
Share Volume:
1M
Fulcrum Therapeutics, Inc. 52-Week Range
52-Week High:
15.74
52-Week Low:
2.32
Sell
40
Fulcrum Therapeutics, Inc. (FULC)
is a Sell
Fulcrum Therapeutics, Inc. Share Price Forecast
-
What is the Fulcrum Therapeutics, Inc. stock price today?The Fulcrum Therapeutics, Inc. stock price is 8.04 USD today.
-
Will FULC stock go up or go down?Fulcrum Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Fulcrum Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics, Inc. is overvalued.
Is Fulcrum Therapeutics, Inc. Stock a Buy?
-
Fulcrum Therapeutics, Inc. share price is 8.04 while FULC 8-day exponential moving average is 7.35, which is a Buy signal.
-
The stock price of FULC is 8.04 while Fulcrum Therapeutics, Inc. 20-day EMA is 7.55, which makes it a Buy.
-
Fulcrum Therapeutics, Inc. 50-day exponential moving average is 8.51 while FULC share price is 8.04, making it a Sell technically.
-
FULC stock price is 8.04 and Fulcrum Therapeutics, Inc. 200-day simple moving average is 8.54, creating a Sell signal.
Fundamental Analysis of Fulcrum Therapeutics, Inc.
Is Fulcrum Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.30 per share.
Technical Analysis of Fulcrum Therapeutics, Inc.
Should I short Fulcrum Therapeutics, Inc. stock?
-
FULC Moving Average Covergence Divergence (MACD) indicator is -0.43, suggesting Fulcrum Therapeutics, Inc. is a Sell
-
Fulcrum Therapeutics, Inc. Relative Strength Index (RSI) is 52.84, which suggest Fulcrum Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Fulcrum Therapeutics, Inc. is (6.94 - 8.04), which suggest Fulcrum Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Fulcrum Therapeutics, Inc. is (8.03 - 11.71), which suggest Fulcrum Therapeutics, Inc. is a Sell
* Fulcrum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.